DP

Dnyansagar Popat Salunke

Active Director Designated Partner DIN 11554682
DIN 11554682 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Dnyansagar Popat Salunke

Data last updated:

Dnyansagar Popat Salunke is a Designated Partner at Celcos Lifesciences Llp (since 2026). The company operates in Pharma.

DIN 11554682
Primary Designation Designated Partner
Industry Pharma
First Appointment 18 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Feb 20262026Active

Board colleagues of Dnyansagar Popat Salunke

NameDINCompanyDesignation
Abhishek Shivaji Salunke11554683Celcos Lifesciences LlpDesignated Partner
Shubham Shankar Nimje11554681Celcos Lifesciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Celcos Lifesciences Llp
Premium access

Shareholding and investment profile for Dnyansagar Popat Salunke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dnyansagar Popat Salunke

Dnyansagar Popat Salunke currently holds 1 directorship: Celcos Lifesciences Llp (Designated Partner, since 18 Feb 2026).

Dnyansagar Popat Salunke was first appointed on 18 Feb 2026 as Designated Partner at Celcos Lifesciences Llp.

The current boards of Dnyansagar Popat Salunke's companies include Abhishek Shivaji Salunke (Celcos Lifesciences Llp), Shubham Shankar Nimje (Celcos Lifesciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available